OXFORD BIOMEDICA

oxford-biomedica-logo

Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research, development and manufacture. Gene therapy is the treatment of disease by delivering therapeutic DNA into a patientโ€™s cells. This can be either in vivo or ex vivo, the latter encompassing the field of cell therapy whereby genetically modified cells are put back into the body. Their pipeline of seven gene and cell therapy therapy products addresses diseases for... which there is currently no treatment or that are inadequately treated today, including ocular and central nervous system disorders. Their product candidates have the potential to transform treatment landscapes. Their strategy is to develop their product candidates to their next value inflection points whilst continuing to build OXB Solutions into a valuable revenue-generating manufacturing and development services business.

#SimilarOrganizations #People #Financial #Website #More

OXFORD BIOMEDICA

Social Links:

Industry:
Biotechnology Genetics Therapeutics

Founded:
1995-01-01

Address:
Oxford, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.oxb.com

Total Employee:
51+

Status:
Active

Contact:
+4401865783000

Email Addresses:
[email protected]

Total Funding:
62.3 M GBP

Technology used in webpage:
SPF Domain Not Resolving Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API Mimecast


Similar Organizations

4bio-capital-logo

4BIO Capital

4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

amsterdam-scientific-instruments-logo

Amsterdam Scientific Instruments

Amsterdam Scientific Instruments specializes in the fields of neutron detection, electron imaging, and X-ray detector technology.

arctos-medical-logo

Arctos Medical

Arctos Medical is a developed gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.

argen-x-logo

arGEN-X

arGEN-X offers a platform for antibody lead choice that supports the discovery of human antibody therapeutics.

batavia-biosciences-logo

Batavia Biosciences

Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product

biocryst-pharmaceuticals-logo

BioCryst Pharmaceuticals

BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina.

celyad-logo

Celyad

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

chameleon-biosciences-logo

Chameleon Biosciences

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

dnadigest-logo

DNAdigest

DNAdigest is a scientific social enterprise that enables the secure sharing and query of genomics data for research.

eg-427-logo

EG 427

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.

enara-bio-logo

Enara Bio

Ervaxx is illuminating the immune interface to develop new cancer therapies.

evaxion-biotech-logo

Evaxion Biotech

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

genetic-analysis-logo

Genetic Analysis

Genetic Analysis has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

coave-therapeutics-logo

Coave Therapeutics

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

horizon-discovery-logo

Horizon Discovery

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

hybrigenics-logo

Hybrigenics

Hybrigenics offers a bioinformatics platforms to identify, validate, and inhibit protein interactions to develop therapeutics for cancer.

immatics-biotechnologies-logo

immatics biotechnologies

immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

immunovia-logo

Immunovia

Immunovia is the center for translational cancer research in Lund, Sweden.

intima-biosciences-logo

Intima Biosciences

Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures.

nouscom-logo

Nouscom

Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

oxford-nanopore-technologies-logo

Oxford Nanopore Technologies

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.

oxford-science-enterprises-logo

Oxford Science Enterprises

Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.

oxford-science-enterprises-logo

Oxford Science Enterprises

Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

reithera-srl-logo

Reithera Srl

Reithera Srl is a company devoted to develop and produce biopharmaceutical products based on gene delivery technologies

riboxx-logo

Riboxx

Riboxx LIFE SCIENCES develops customized and tailor-made molecular tools for gene silencing in vitro and in vivo through RNA interference:

roslinct-logo

RoslinCT

RoslinCT is a UK Cell Therapy Contract Development and Manufacturing Organisation.

sino-biocan-logo

Sino-Biocan

Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.

t-knife-logo

T-knife

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

xenothera-logo

Xenothera

Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.


Current Advisors List

john-dawson_image

John Dawson Board Director @ Oxford BioMedica
Board_member
2022-01-01

patrick-aebischer_image

Patrick Aebischer Member of the Scientific Advisory Boards @ Oxford BioMedica
Advisor

roch-doliveux_image

Roch Doliveux Chairman Of The Board @ Oxford BioMedica
Board_member
2020-01-01

Current Employees Featured

kyriacos-mitrophanous_image

Kyriacos Mitrophanous
Kyriacos Mitrophanous Chief Scientific Officer @ Oxford BioMedica
Chief Scientific Officer

stuart-paynter_image

Stuart Paynter
Stuart Paynter Chief Financial Officer @ Oxford BioMedica
Chief Financial Officer

jason-slingsby_image

Jason Slingsby
Jason Slingsby Chief Business Officer @ Oxford BioMedica
Chief Business Officer

james-miskin_image

James Miskin
James Miskin Chief Technical Officer @ Oxford BioMedica
Chief Technical Officer
2014-10-01

lorenzo-tallarigo_image

Lorenzo Tallarigo
Lorenzo Tallarigo Chairman @ Oxford BioMedica
Chairman

helen-stephenson-ellis_image

Helen Stephenson-Ellis
Helen Stephenson-Ellis Chief People Officer @ Oxford BioMedica
Chief People Officer

dmitry-zamoryakhin_image

Dmitry Zamoryakhin
Dmitry Zamoryakhin Chief Medical Officer @ Oxford BioMedica
Chief Medical Officer

nick-page_image

Nick Page
Nick Page Chief Operations Officer @ Oxford BioMedica
Chief Operations Officer

david-davies_image

David Davies
David Davies Programme Director (interim) @ Oxford BioMedica
Programme Director (interim)

Founder


not_available_image

Alan Kingsman

not_available_image

Susan Kingsman

Stock Details


Company's stock symbol is LSE:OXB

Acquisitions List

Date Company Article Price
2007-03-12 Oxxon Therapeutics Oxxon Therapeutics acquired by Oxford BioMedica 16 M GBP

Investors List

serum-institute-of-india-pvt-ltd_image

Serum Institute of India Pvt. Ltd.

Serum Institute of India Pvt. Ltd. investment in Post-IPO Equity - Oxford BioMedica

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Oxford BioMedica

Official Site Inspections

http://www.oxb.com Semrush global rank: 496.53 K Semrush visits lastest month: 100.57 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Oxford BioMedica" on Search Engine